Both in Biotechnology
Alector vs Fate Therapeutics
Over the past year ALEC returned +42.4% and FATE returned +61.9%; their daily moves had a correlation of 0.28.
ALEC +42.4% FATE +61.9%Growth of $1, one year, split-adjusted
| Metric | ALEC | FATE |
|---|---|---|
| Price | $2.05 | $2.04 |
| Market cap | $228.9M | $244.4M |
| Today | −4.65% | +1.49% |
| 1 month | +3.0% | −16.0% |
| 6 months | −20.2% | −13.6% |
| Year to date | +31.4% | +107.6% |
| 1 year | +39.5% | +51.1% |
| Revenue growth (YoY) | −57.8% | +9.2% |
| Gross margin | 100.0% | 100.0% |
| Net margin | −692.5% | −1448.6% |
| P/E (TTM) | — | — |
| Price / sales | 16.5× | 37.7× |
| Net cash | $162.9M | $153.8M |
| Dividend yield | — | — |
| Volatility (60d) | 93.3% | 56.1% |
| Short % of float | 11.1% | 10.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).